Ernexa Therapeutics Inc. (ERNA) Gross profit 2023–2025
Ernexa Therapeutics Inc. (ERNA) annual gross profit history from SEC filings — each fiscal year as reported.
$486,000FY2025 · since FY2023: $0 → $486,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $486,000 | +389.3% |
| FY2024 | -$168,000 | — |
| FY2023 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ERNA financial trends
ERNA RevenueERNA Net incomeERNA Net marginERNA Gross marginERNA Operating incomeERNA Operating marginERNA Operating cash flowERNA Free cash flowERNA Capital expendituresERNA Return on equityERNA Stock buybacksERNA Dividends paidERNA Total assetsERNA Total liabilitiesERNA Shareholders’ equityERNA overview →